Skip to main content
Year archive

Fredun Pharmaceuticals Limited — 2025 filings

All 100 regulatory filings released by Fredun Pharmaceuticals Limited (539730) in 2025, sourced directly from the official regulator.

100 Filings
2025 Period
2025 filings (100)
Filing Released Lang
Closure of Trading Window
Regulatory Filings
2025-12-31 English
Revised Announcement for Allotment of Equity Shares and Warrants on Preferential Basis.
Regulatory Filings
2025-12-29 English
Allotment of Equity Shares and Warrants on Preferential Basis.
Regulatory Filings
2025-12-29 English
Corrigendum through General Announcement regarding disclosure of Pre-Preferential shareholding of Proposed allottees, Ultimate Beneficial Owners (UBO''s), Revised issue size of Proposed ....
Regulatory Filings
2025-12-18 English
Corrigendum through General Announcement regarding disclosure of Pre-Preferential Shareholding of Proposed Allottees, Ultimate Beneficial Owners (UBOs), Revised Issue Size of Proposed Preferential ...
Regulatory Filings
2025-12-18 English
Outcome of Analyst/Investors meeting
Regulatory Filings
2025-12-17 English
Intimation of Schedule of 'Value Discovery Summit', under the SEBI (Listing Obligations and Disclosure Requirement), Regulation 2015.
Regulatory Filings
2025-12-11 English
Corrigendum through General Announcement regarding disclosure of Ultimate Beneficial Owners (UBO''s), Pre - Preferential Shareholding of Proposed Allotees and bifurcation and bried description ....
Regulatory Filings
2025-11-29 English
Appointment of Company Secretary and Compliance Officer w.e.f. 28.11.2025
Regulatory Filings
2025-11-28 English
Announcement as per Regulation 30 for Appointment of Non-Executive Independent Director.
Regulatory Filings
2025-11-28 English
Intimation under regulation 30 for appointment of Ms. Pooja Narendra Sanghavi as Non Executive Independent Director.
Regulatory Filings
2025-11-28 English
Genreral Announcement pertaining to disclosure of Ultimate Benificial Owners (UBOs) of Proposed Allottees in connection with the Extra-Ordinary General Meeting (EGM) held on October 22, 2025.
Regulatory Filings
2025-11-15 English
Transcript of the Earnings Conference call held on 11th November 2025 for Q2 & H1 FY26.
Regulatory Filings
2025-11-14 English
Website Link of Audio Recording of the Q2 FY26 "Earnings Conference Call"
Regulatory Filings
2025-11-12 English
Newspaper AD of the Unaudited Financial Statements for the quarter and half year ended 30th September, 2025.
Regulatory Filings
2025-11-11 English
Please find enclosed press release titled "Fredun Pharmaceuticals Reports 61% YoY Growth in EBITDA to 39.33 Cr in H1 FY26" issued by Fredun Pharmaceutcals Limited.
Regulatory Filings
2025-11-10 English
Revised Financial Results for the Quarter Ended 30th September, 2025.
Regulatory Filings
2025-11-09 English
Mr. Parag Goyal has tendered his resignation from the post of Company Secretary and Compliance Officer w.e.f. closing of working hours on 26th November, 2025.
Regulatory Filings
2025-11-08 English
Outcome of Board Meeting along with the results for the quarter ended 30th September, 2025.
Regulatory Filings
2025-11-08 English
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting ....
Regulatory Filings
2025-11-08 English
Intimation of Earnings Conference Call for the quarter ended Q2 & H1 FY26
Regulatory Filings
2025-11-06 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve 1. To discuss, consider ....
Regulatory Filings
2025-10-28 English
Scrutinizer Report for the Extra Ordinary General Meeting dated 22nd October, 2025
Regulatory Filings
2025-10-22 English
Outcome of the Extra Ordinary General Meeting dated 22nd October, 2025.
Regulatory Filings
2025-10-22 English
Corrigendum I to the Notice of Extraordinary General Meeting to be held on 22nd October, 2025.
Regulatory Filings
2025-10-17 English
Press Release issued by Fredun Pharmaceuticals Limited
Regulatory Filings
2025-10-13 English
Certificate under Regulation 74(5) of the SEBI ( Depositories & Participants) Regulations, 2018
Regulatory Filings
2025-10-11 English
Press release issued by the company
Regulatory Filings
2025-10-09 English
Cessation of 2 Independent Directors on Tenure Completion.
Regulatory Filings
2025-10-06 English
Newspaper Clipping- Information regarding EOGM to be held on 22.10.2025
Regulatory Filings
2025-10-01 English
Scrutinizer Report and Voting Results for the AGM held on 30.09.2025
Regulatory Filings
2025-10-01 English
Intimation of Record date for the purpose of EOGM of the Company.
Regulatory Filings
2025-09-30 English
Notice of book closure for the purpose of EOGM to be held on 22nd October, 2025
Regulatory Filings
2025-09-30 English
Notice Convening EOGM of the Company.
Regulatory Filings
2025-09-30 English
Intimation under Regulation 30 of SEBI (LODR) Regulation 2015
Regulatory Filings
2025-09-30 English
Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015
Regulatory Filings
2025-09-30 English
Outcome of 38th Annual General Meeting in compliance with Regulation 30 of SEBI (LODR) Regulation 2015
Regulatory Filings
2025-09-30 English
Newspaper Clipping - Information regarding Extra-Ordinary General Meeting to be held through VC/OAVM
Regulatory Filings
2025-09-27 English
Intimation of Trading Window Closure
Regulatory Filings
2025-09-26 English
Outcome of Board Meeting held on 25th September, 2025 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ....
Regulatory Filings
2025-09-25 English
Closure of Trading Window
Regulatory Filings
2025-09-22 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 ,inter alia, to consider and approve Dear Sir/ Madam, We ....
Regulatory Filings
2025-09-22 English
NEWSPAPER CLIPPING INFORMATION REGARDING 38TH ANNUAL GENERAL MEETING TO BE HELD THROUGH VIDEO CONFERENCE (VC)/ OTHER AUDIO VISUAL MEANS (OAVM)
Regulatory Filings
2025-09-09 English
Intimation under Reg 30 of the SEBI LODR Reg, 2015
Regulatory Filings
2025-09-08 English
Intimation of record date for the purpose of final dividend for FY 2024-25
Regulatory Filings
2025-09-08 English
Notice of Book Closure for the purpose of 38th AGM
Regulatory Filings
2025-09-08 English
Submission of the 38th Annual Report including Notice of AGM of Company for the FY 2024-25
Regulatory Filings
2025-09-08 English
Submission of the 38th Annual Report of Fredun Pharmaceuticals Limited for the Financial Year 2024-25.
Regulatory Filings
2025-09-08 English
NEWSPAPER CLIPPING INFORMATION REGARDING 38TH ANNUAL GENERAL MEETING TO BE HELD THROUGH VIDEO CONFERENCE (VC)/ OTHER AUDIO VISUAL MEANS (OAVM).
Regulatory Filings
2025-09-03 English
INTIMATION OF INVESTOR MEETING IN CHENNAI UNDER REGULATION 30 OF SEBI (LODR) REGULATION 2015 ON 5TH SEPTEMBER, 2025.
Regulatory Filings
2025-09-02 English
Pursuant to Regulation 30 read with sub para 15, Para A Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Senior ....
Regulatory Filings
2025-08-23 English
TRANSCRIPT OF THE EARNINGS CONFERENCE CALL HELD ON 1ST AUGUST 2025 FOR Q1 FY26 RESULTS.
Regulatory Filings
2025-08-06 English
Audio Recording of the Q1 FY26 "Earnings Conference Call"
Regulatory Filings
2025-08-01 English
Audio Recording of the Q1 FY25 "Earnings Conference Call"
Regulatory Filings
2025-08-01 English
Press release issued by Fredun Pharmaceuticals Limited.
Regulatory Filings
2025-07-31 English
Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.
Regulatory Filings
2025-07-30 English
Appointment of non-excecutive Independent Directors.
Regulatory Filings
2025-07-30 English
Appointment of Non-Executive Independent Directors Mr. Anshu Agarwal and Mrs. Sonal Desai.
Regulatory Filings
2025-07-30 English
Un-audited Results of the Company for the quarter ended 30th June 2025 along with Limited review report.
Regulatory Filings
2025-07-30 English
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting ....
Regulatory Filings
2025-07-30 English
Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule III of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015, ....
Regulatory Filings
2025-07-30 English
Intimation of Earnings Conference Call for the quarter ended 30th June, 2025
Regulatory Filings
2025-07-29 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve Notice is hereby given ....
Regulatory Filings
2025-07-14 English
Voluntary Disclosure - SEBI Adjudication Order Dated June 30, 2025 (No Penalty Imposed)
Regulatory Filings
2025-07-10 English
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018.
Regulatory Filings
2025-07-09 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with our internal policy on disclosure of events and information, ....
Regulatory Filings
2025-07-03 English
Closure of Trading Window
Regulatory Filings
2025-06-30 English
Fredun Pharmaceuticals enters pet care market with one pet stop acquisition.
Regulatory Filings
2025-06-30 English
Intimation of demise of Mr. Nariman Medhora under Regulation 30 of SEBI (LODR) Reg, 2015
Regulatory Filings
2025-06-20 English
INVESTORS PRESENTATION
Regulatory Filings
2025-06-10 English
INVESTOR PRESENTATION OF FREDUN PHARMACEUTICALS LIMITED
Regulatory Filings
2025-06-10 English
Revised Outcome of the Board Meeting dated 30.05.2025
Regulatory Filings
2025-05-31 English
Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 2025 along with Statement of Assets and Liabilities and Cash Flow Statement
Regulatory Filings
2025-05-31 English
Press Release of Fredun Pharmaceuticals for Q4 and FY25 Robust Performance.
Regulatory Filings
2025-05-30 English
Intimation of re-appointment of Secretarial Auditor, Internal Auditor and Cost Auditor.
Regulatory Filings
2025-05-30 English
Standalone and Consolidated Financial results for the period ended on 31st March 2025.
Regulatory Filings
2025-05-30 English
To consider approve and adopt The Standalone and consolidated Audited Financial Results for the Quarter and Financial year ended March, 31 2025
Regulatory Filings
2025-05-30 English
Annual Secretarial Compliance Report for the FY year ended 31st March, 2025.
Regulatory Filings
2025-05-30 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given ....
Regulatory Filings
2025-05-22 English
Appointment of Company Secretary and Compliance Officer.
Regulatory Filings
2025-05-17 English
Appointment of Company Secretary and Compliance Officer.
Regulatory Filings
2025-05-17 English
Certificate Pursuant to Regulation 74(5) of the SEBI (DP) Reg, 2018
Regulatory Filings
2025-04-15 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2025-04-09 English
The company has secured a tender from Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines,valued between Rs.150 million and Rs. 180 million
Regulatory Filings
2025-04-09 English
Announcement regarding upgradation of ratings assigned to its bank facilities by Infomerics Valuation and Rating Ltd.The upgrade reflects the company''s strong financial performance and ....
Regulatory Filings
2025-04-03 English
Intimation of Closure of trading window
Regulatory Filings
2025-03-27 English
Fredun Pharma''s Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.
Regulatory Filings
2025-03-18 English
THE COMPANY ANNOUNCES ITS FORAY INTO THE LARGE ANIMAL VETERINARY SEGMENT BY PROVIDING INNOVATIVE SOLUTIONS FOR LARGE ANIMAL HEALTH TO ADDRESS THEIR KEY HEALTH CHALLENGES.
Regulatory Filings
2025-03-11 English
We wish to inform you that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its meeting held today i.e. on February 24, 2025, has approved ....
Regulatory Filings
2025-02-24 English
We wish to inform you that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its meeting held today i.e. on February 24, 2025, has approved ....
Regulatory Filings
2025-02-24 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Resignation of Company Secretary and Compliance Officer.
Regulatory Filings
2025-02-19 English
Fredun Pharmaceuticals Reports Exceptional Q3 and 9M FY25 Performance
Regulatory Filings
2025-02-04 English
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2025-02-04 English
Unaudited Financial Results for the quarter and nine months ended 31.12.2024 along with Integrated Filing (Financial).
Regulatory Filings
2025-02-04 English
Unaudited Financial Results for the quarter and nine months ended 31.12.2024
Regulatory Filings
2025-02-04 English
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting ....
Regulatory Filings
2025-02-04 English
Fredun Pharmaceuticals Enhances Production Capacities with it''s Second Italian Tube Filling Machine, Boosting Capacity by 2.9x.
Regulatory Filings
2025-02-03 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve Prior Intimation for ....
Regulatory Filings
2025-01-22 English
Certificate Pursuant to Regulation 74(5) of the SEBI(DP) Regulations,2018.
Regulatory Filings
2025-01-15 English
Press Release
Regulatory Filings
2025-01-09 English